☆ 4.6 Article

Rational Engineering of a Sub-Picomolar HIV-1 Blocker

VIRUSES-BASEL (2022)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Update and latest advances in antiretroviral therapy

Luis Menendez-Arias et al.

Summary: Since the first cases of AIDS appeared in 1981, HIV-1 infection has become a global pandemic, but research has led to the approval of over 30 antiretroviral drugs and combination therapies turning HIV-1 infection into a chronic but manageable disease. However, drug toxicity and acquired and transmitted drug resistance remain major threats to therapy success.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Add to Collection

Article Immunology

Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis

Yerkezhan Amerzhanova et al.

Summary: This perspective provides an overview of CCR5 as a central molecular determinant and its potential therapeutic applications. The study focuses on CCR5 antagonism and its impact on receptor-ligand interactions. The analysis of CCL5 mutants reveals the potential for enhanced anti-HIV-1 activity. Furthermore, the exploration of strategies such as improving CCR5 interaction in regions distal to the chemokine N-terminus and developing allosteric antagonists opens up new possibilities for CCR5 blockade.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Hager Mohamed et al.

Summary: HIV-1 infection is a global health burden, and current drug therapies face challenges. Novel anti-HIV-1 therapies targeting CCR5 have shown promise in preventing infection and are included in gene editing techniques, CCR5 blockade using antibodies or antagonists, or combinations of both.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)

Sergi Ferre et al.

Summary: The study proposes the concept of GPCR-effect assemblies (GEMMAs), which are pre-assembled before receptor activation and allow more efficient interactions between specific signaling components. This offers an alternative model to the conventional collision coupling model and explains the differential properties of GPCRs in different cellular environments.

PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Microbiology

Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species

Xiao L. Chang et al.

Summary: The CCR5-specific antibody Leronlimab has shown to be a safe and effective immunotherapy for suppressing HIV replication without significant side effects. It can fully occupy CCR5 receptors on CD4+ T cells and monocytes, leading to long-term virologic suppression in both humans and macaques.

PLOS PATHOGENS (2022)

Add to Collection

Article Biology

Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status

Fanny Momboisse et al.

Summary: This study investigated the impact of different states on the biological function and therapeutic targeting of CC chemokine receptor 5 (CCR5). The researchers used microscopy and statistical methods to track and classify the motion of different receptor subpopulations. The results showed that CCR5 exists in various ligand-free forms, stabilized by different ligands. Agonist stimulation restricted the mobility of CCR5 and led to its clustering, while inverse agonist stimulation had the opposite effect. The study also demonstrated the importance of CCR5 dimerization in its coupling to G proteins, immobilization and clustering upon activation, and receptor endocytosis.

ELIFE (2022)

Add to Collection

Article Immunology

Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis

Saida Mukanova et al.

Summary: Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract, and its pathogenesis involves complex interactions of various factors. This study investigates the potential crosstalk between the periostin and CCR5 signaling systems and evaluates the therapeutic potential of a CCL5 derivative as a CCR5 antagonist in an IBD model.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

CCL5/CCR5 axis in human diseases and related treatments

Zhen Zeng et al.

Summary: This review discusses the role of the CCL5/CCR5 axis in the pathological processes of different diseases, including inflammation, chronic diseases, cancers, and COVID-19. It also highlights the regulation of relevant signaling pathways and research and clinical trials for treating CCR5-related diseases.

GENES & DISEASES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Risks and benefits of reducing the number of drugs to treat HIV-1 infection

Julen Cadinanos et al.

Summary: Reducing the number of drugs in antiretroviral therapy to two-drug regimens has shown comparable efficacy and short-term safety in some cases, with potential benefits that may outweigh the risks, despite the need for further research on long-term safety and the mixed success of some two-drug regimens.

EXPERT OPINION ON DRUG SAFETY (2021)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

mRNA vaccines offer hope for HIV

Lynn Morris

Summary: mRNA technology is believed to be uniquely positioned for developing HIV vaccines, and a preclinical study has taken the first step towards this goal of eliciting broadly cross-reactive neutralizing antibodies.

NATURE MEDICINE (2021)

Add to Collection

Article Immunology

Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers

Ian Michael McGowan et al.

Summary: The study evaluated the safety and acceptability of OB-002H gel, showing good tolerability and acceptability with no evidence of systemic absorption and only a few mild product-related adverse events.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)

Add to Collection

Review Immunology

Broadly neutralizing antibodies for HIV-1 prevention and therapy

Boris Julg et al.

Summary: The discovery of potent and broadly neutralizing antibodies against HIV-1 has led to significant advancements in developing tools for the prevention and treatment of HIV-1 infections, showing promise for clinical use.

SEMINARS IN IMMUNOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

A Two-Birds-One-Stone Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat Region

Chao Wang et al.

Summary: This study reports a dual-targeted drug compound with bifunctional entry inhibitors that effectively block HIV-1 entry. One chimera, CP12TAK, shows potent antiviral activity against both R5-tropic viruses and X4-tropic HIV-1 strains, suggesting promising potential for further development as a new anti-HIV-1 drug. Results indicate that this strategy could be extended to design therapies against infection of other enveloped viruses.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Virology

Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor

Celien Jacquemard et al.

Summary: Research shows that different variants of HIV-1 gp120 binding to CCR5 can result in changes in receptor conformation, including reshaping of extracellular loops 2 and 3, affecting accessibility to the transmembrane binding cavity, and positioning movements in different protein regions.

VIRUSES-BASEL (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5

Hui Zhang et al.

Summary: The chemokine receptor CCR5 plays multiple roles in the immune system. The structures of G(i1) protein-coupled CCR5 with or without a chemokine bound, as well as the CCR5- chemokine MIP-1 alpha complex, offer insights into the distinct binding modes of the ligands and the mechanism of CCR5 activation.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

Polina Isaikina et al.

Summary: The study reveals the structure and activation mechanism of CCR5, showing how chemokine agonists transmit activation signals through the receptor. It also finds differences in the activity relationship and activation mechanism between agonist and antagonist chemokines.

SCIENCE ADVANCES (2021)

Add to Collection

Review Immunology

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention

Kathryn E. Stephenson et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Add to Collection

Article Pharmacology & Pharmacy

Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES

John W. McBride et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins

Samuel Jurado et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Molecular Mechanism of HIV-1 Entry

Bing Chen

TRENDS IN MICROBIOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of coreceptor recognition by HIV-1 envelope spike

Md Munan Shaik et al.

NATURE (2019)

Add to Collection

Review Multidisciplinary Sciences

Why and where an HIV cure is needed and how it might be achieved

Thumbi Ndung'u et al.

NATURE (2019)

Add to Collection

Review Chemistry, Medicinal

Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?

Sonia de Castro et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Cell Biology

Remodeling our concept of chemokine receptor function: From monomers to oligomers

Laura Martinez-Munoz et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2018)

Add to Collection

Article Chemistry, Medicinal

Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface

Adel A. Rashad et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Article Multidisciplinary Sciences

Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers

Massimiliano Secchi et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Review Immunology

The Expanding Therapeutic Perspective of CCR5 Blockade

Luca Vangelista et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist RevealsMechanisms of Chemokine Recognition and Molecular Mimicry by HIV

Yi Zheng et al.

IMMUNITY (2017)

Add to Collection

Article Microbiology

Combination of the CCL5-Derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5

Massimiliano Secchi et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry

Bo Zhao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Add to Collection

Article Multidisciplinary Sciences

Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use

Rebecca Nedellec et al.

PLOS ONE (2011)

Add to Collection

Article Microbiology

Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers

Luca Vangelista et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Add to Collection

Article Virology

Resistance to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Rebecca Nedellec et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Biochemical Research Methods

The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants

Massimiliano Secchi et al.

PROTEIN EXPRESSION AND PURIFICATION (2009)

Add to Collection

Article Multidisciplinary Sciences

Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide

Hubert Gaertner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Add to Collection

Article Virology

Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1

Erhard Kopetzki et al.

VIROLOGY JOURNAL (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Steric accessibility of the HIV-1 gp41 N-trimer region

AE Hamburger et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Article Multidisciplinary Sciences

Protein design of an HIV-1 entry inhibitor

MJ Root et al.

SCIENCE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.